Conventional proton pump inhibitors (PPIs) are used as a first-line therapy to treat acid-
related diseases worldwide. However, they have a number of limitations including slow …

Background Potassium‐competitive acid blockers (P‐CABs) are a novel group of acid‐
suppressing medicines for the management of acid‐related disorders. Aims To review …

Aspirin and P2Y 12 receptor antagonists are widely used across the spectrum of
cardiovascular and cerebrovascular diseases. Gastrointestinal complications, including …

Objective To assess the non-inferiority of vonoprazan to lansoprazole for secondary
prevention of non-steroidal anti-inflammatory drug (NSAID)-induced peptic ulcer (PU) and …

Abstract Purpose of the Review Acid suppression with proton pump inhibitors (PPIs)
represents the standard of care in the treatment of acid-related diseases. However, despite …

Although proton pump inhibitors (PPIs) have been used widely, acid-related diseases are
still associated with a huge burden on the health care system. Recently, the efficacy and …

Abstract Purpose of Review Despite the many areas of unmet needs in gastroesophageal
reflux disease (GERD), proton pump inhibitors (PPIs) remain the cornerstone of medical …

Aspirin, other antiplatelet agents, and anticoagulant drugs are used across a wide spectrum
of cardiovascular and cerebrovascular diseases. A concomitant proton pump inhibitor (PPI) …

ABSTRACT Introduction Proton pump inhibitors (PPIs) are the first-line treatment for
gastroesophageal reflux disease (GERD). However, due to their intrinsic limitations, there …

Purpose of the review The introduction of H 2-receptor antagonists (H 2 RAs) and proton
pump inhibitors (PPIs) into clinical practice has been a real breakthrough in the treatment of …